Term Name: EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor
Synonyms: CFA synthase inhibitor, CFA synthase inhibitors, cyclopropane fatty acid synthase inhibitors, cyclopropane fatty acid synthetase inhibitor, cyclopropane fatty acid synthetase inhibitors, cyclopropane synthase inhibitor, cyclopropane synthase inhibitors, cyclopropane synthetase inhibitor, cyclopropane synthetase inhibitors, cyclopropane-fatty-acyl-phospholipid synthase (EC 2.1.1.79) inhibitor, cyclopropane-fatty-acyl-phospholipid synthase (EC 2.1.1.79) inhibitors, cyclopropane-fatty-acyl-phospholipid synthase inhibitor, cyclopropane-fatty-acyl-phospholipid synthase inhibitors, EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitors, EC 2.1.1.79 inhibitor, EC 2.1.1.79 inhibitors, S-adenosyl-L-methionine:unsaturated-phospholipid methyltransferase (cyclising) inhibitor, S-adenosyl-L-methionine:unsaturated-phospholipid methyltransferase (cyclising) inhibitors, S-adenosyl-L-methionine:unsaturated-phospholipid methyltransferase (cyclizing) inhibitor, S-adenosyl-L-methionine:unsaturated-phospholipid methyltransferase (cyclizing) inhibitors, unsaturated-phospholipid methyltransferase inhibitor, unsaturated-phospholipid methyltransferase inhibitors
Definition: An EC 2.1.1.* (methyltransferases) inhibitor that interferes with the action of cyclopropane fatty acid synthase (EC 2.1.1.79).
Ontology: ChEBI [CHEBI:65064]  ( EBI )

Relationships
is a type of: EC 2.1.1.* (methyltransferases) inhibitor
inverse has_role: S-adenosyl-L-homocysteine